Proactive Therapeutic Drug Monitoring Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease Treated With Intravenous Vedolizumab.
Porth, Rachel, Tina Deyhim, Samantha Zullow, Loren G Rabinowitz, Laurie B Grossberg, Xavier Roblin, Stephane Paul, Adam S Cheifetz, and Konstantinos Papamichael. 2025. “Proactive Therapeutic Drug Monitoring Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease Treated With Intravenous Vedolizumab.”. Inflammatory Bowel Diseases 31 (2): 485-91.